Your browser doesn't support javascript.
loading
FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling.
Liebig, Sven; Neumann, Martin; Silva, Patricia; Ortiz-Tanchez, Jutta; Schulze, Veronika; Isaakidis, Konstandina; Schlee, Cornelia; Schroeder, Michael P; Beder, Thomas; Morris, Luc G T; Chan, Timothy A; Bastian, Lorenz; Burmeister, Thomas; Schwartz, Stefan; Gökbuget, Nicola; Mochmann, Liliana H; Baldus, Claudia D.
Afiliação
  • Liebig S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Hindenburgdamm 30, 12203, Berlin, Germany. sven.liebig@charite.de.
  • Neumann M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Silva P; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Ortiz-Tanchez J; University Hospital Schleswig-Holstein, Campus Kiel, Department of Hematology and Oncology, Kiel, Germany.
  • Schulze V; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Isaakidis K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Schlee C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Schroeder MP; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Beder T; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Genomics, Berlin, Germany.
  • Morris LGT; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Chan TA; University Hospital Schleswig-Holstein, Campus Kiel, Department of Hematology and Oncology, Kiel, Germany.
  • Bastian L; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Burmeister T; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Schwartz S; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10064, USA.
  • Gökbuget N; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mochmann LH; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Baldus CD; University Hospital Schleswig-Holstein, Campus Kiel, Department of Hematology and Oncology, Kiel, Germany.
Sci Rep ; 13(1): 972, 2023 01 18.
Article em En | MEDLINE | ID: mdl-36653435
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Adult / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Adult / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article